A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(10 sites)

China

Cancer Hospital of Chinese Academy of Medical Sciences, Beijing, Beijing Municipality

Beijing Chaoyang Hospital, Capital Medical University, Beijing, Beijing Municipality

Beijing Cancer Hospital, Beijing, Beijing Municipality

Beijing Chest Hospital, Capital Medical University, Beijing, Beijing Municipality

Fujian Medical University Union Hospital, Fuzhou, Fujian

Weifang People's Hospital, Weifang, Shandong

Shanghai Chest Hospital, Shanghai, Shanghai Municipality

Shanxi Cancer Hospital, Taiyuan, Shanxi

Tianjin Medical University General Hospital, Tianjin, Tianjin Municipality

Tianjin Chest Hospital, Tianjin, Tianjin Municipality